

titleRNAa technology to selectively turn genes on using saRNA
Early-stage pharma company creating first-in-class therapies boosting expression of therapeutic genes in diseased cells using saRNA.
- 公司名称:Ractigen Therapeutics
- -
- 2年前
- 2015-03-29
2年前
时常
$100
技术支出
销售支出
4.9
Finder overall rating
联系方式
Phone
暂无
Email
***@ ractigen.com
***@ ractigen.com
***@ ractigen.com
Twitter
twitter.com/ractigen_tx
Tiktok
暂无
Facebook
暂无
Linkedin
linkedin.com/company/ractigen-therapeutics
Google
暂无
Instagram
暂无
Youtube
暂无